RXHERE

Serial Number 77031187
602

Registration Progress

Application Filed
Oct 27, 2006
Under Examination
Aug 12, 2008
Approved for Publication
Jan 23, 2008
Published for Opposition
Feb 12, 2008
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: RXHERE
Previous Owner: LEVREGY, LLC
Classes: 005

Trademark Image

RXHERE

Basic Information

Serial Number
77031187
Filing Date
October 27, 2006
Published for Opposition
February 12, 2008
Abandonment Date
September 4, 2009
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Oct 5, 2009
Classes
005

Rights Holder

LEVREGY, LLC

16
Address
BUILDING 100, SUITE B
4931 RIVERSIDE DR.
MACON, GA 31210

Ownership History

Levregy Inc.

Original Applicant
03
Macon, GA

Levregy Inc.

Owner at Publication
03
Macon, GA

LEVREGY, LLC

New Owner After Publication #1
16
MACON, GA

Legal Representation

Attorney
Nathaniel A. Humphries

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

31 events
Date Code Type Description Documents
Oct 5, 2009 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Oct 5, 2009 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Mar 4, 2009 CNRT O NON-FINAL ACTION MAILED Loading...
Mar 3, 2009 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Feb 6, 2009 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jan 21, 2009 IUAF S USE AMENDMENT FILED Loading...
Feb 6, 2009 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 21, 2009 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Nov 12, 2008 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Aug 12, 2008 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 27, 2008 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Mar 11, 2008 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Feb 12, 2008 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 23, 2008 NPUB O NOTICE OF PUBLICATION Loading...
Dec 7, 2007 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Nov 29, 2007 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Nov 21, 2007 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 19, 2007 CNEA O EXAMINERS AMENDMENT MAILED Loading...
Nov 19, 2007 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 19, 2007 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 1, 2007 CNFR O FINAL REFUSAL MAILED Loading...
Oct 31, 2007 CNFR R FINAL REFUSAL WRITTEN Loading...
Oct 2, 2007 ACEC I AMENDMENT FROM APPLICANT ENTERED Loading...
Oct 2, 2007 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 2, 2007 ALIE A ASSIGNED TO LIE Loading...
Aug 22, 2007 MAIL I PAPER RECEIVED Loading...
Mar 15, 2007 CPRA F PRIORITY ACTION MAILED Loading...
Mar 15, 2007 CPRA R PRIORITY ACTION WRITTEN Loading...
Mar 8, 2007 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 1, 2006 MPMK O NOTICE OF PSEUDO MARK MAILED Loading...
Oct 31, 2006 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, antibacterial products, astringents, cardiovascular products, dermatological products, inhaled preparations for the treatment of respiratory diseases and disorders, ocular products, antitussive-cold preparations, anti-allergic preparations, anticoagulant products, antidepressant products, appetite suppressants, products for treatment of gout, products for treatment of heart rhythm disorders, products for treatment of infectious diseases, products for treatment of central nervous system, gastro-intestinal disease treatment products, inhalation preparations for the treatment of pulmonary hypertension, preparations for the treatment of hormonal disorders and the prevention of osteoporosis, preparations for treating allergic rhinitis and asthma, preparations for treating diabetes, skin disorder treatments, preparations for wound treatment, preparations for use in urology, preparations for the treatment of eye diseases and conditions, products for the treatment of viral and infectious diseases, products for the treatment of cancer, products for treating respiratory diseases, skin lotion, products for the treatment of erectile dysfunction, lipid lowering agents, anti-infectives, blood pressure lowering agents in the nature of Ace inhibitors, pain relieving agents in the nature of analgesics, anticonvulsants for the prevention of seizures, anti-diarrheals for the control or stopping of diarrhea, antiemetics for controlling or stopping nausea, products for calming nervous and muscular spasms or convulsions in the nature of antispasmotics, products for destroying or weakening a virus in the nature of antivirals, products for increasing the flow of urine in the nature of diuretics, products for relieving pain in the nature of prescription narcotics, products for reducing skeletal muscle contraction in the nature of skeletal muscle relaxants, products for treating swelling and inflammation in the nature of steroids, products for thyroid control, and anti-inflammatory non-steroidal products (NSAID)
First Use Anywhere: Jun 19, 2007
First Use in Commerce: Aug 21, 2007

Additional Information

Pseudo Mark
RX HERE

Classification

International Classes
005